Abstract
Oral cancer accounts for 2-3% of all malignancies and according to the World Health Organization (WHO) is the fifth most common cancer worldwide. On the other hand, “oxidative stress” implies a cellular state whereby reactive oxygen species (ROS) production exceeds its metabolism resulting in excessive ROS accumulation and overwhelmed cellular defenses. Such a state has been shown to be involved in the multistage process of human carcinogenesis (including oral cancer) via many different mechanisms. Amongst them are ROS-induced oxidative modifications on major cellular macromolecules like DNA, proteins and lipids with the resulting byproducts being involved in the pathophysiology of human oral malignant and pre-malignant lesions. Throughout this manuscript, we review the current state of knowledge on the role of these oxidativemodified cellular byproducts in serving as reliable biomarkers for oral cancer detection, prognosis and diagnosis.
Keywords: Reactive Oxygen Species (ROS), Oxidative Stress, Lipid Oxidation, DNA Oxidation, Protein Oxidation, Oral Carcinogenesis, OSCC, Leukoplakia, Lichen Planus, Submucous Fibrosis, tobacco, infection, intraoral cancer, chemotherapy, radiotherapy
Current Molecular Medicine
Title:Oxidative Stress Based-Biomarkers in Oral Carcinogenesis: How Far Have We Gone?
Volume: 12 Issue: 6
Author(s): R. Hanafi, I. Anestopoulos, G. P. Voulgaridou, R. Franco, A. G. Georgakilas, D. Ziech, V. Malamou-Mitsi, A. Pappa and M. I. Panayiotidis
Affiliation:
Keywords: Reactive Oxygen Species (ROS), Oxidative Stress, Lipid Oxidation, DNA Oxidation, Protein Oxidation, Oral Carcinogenesis, OSCC, Leukoplakia, Lichen Planus, Submucous Fibrosis, tobacco, infection, intraoral cancer, chemotherapy, radiotherapy
Abstract: Oral cancer accounts for 2-3% of all malignancies and according to the World Health Organization (WHO) is the fifth most common cancer worldwide. On the other hand, “oxidative stress” implies a cellular state whereby reactive oxygen species (ROS) production exceeds its metabolism resulting in excessive ROS accumulation and overwhelmed cellular defenses. Such a state has been shown to be involved in the multistage process of human carcinogenesis (including oral cancer) via many different mechanisms. Amongst them are ROS-induced oxidative modifications on major cellular macromolecules like DNA, proteins and lipids with the resulting byproducts being involved in the pathophysiology of human oral malignant and pre-malignant lesions. Throughout this manuscript, we review the current state of knowledge on the role of these oxidativemodified cellular byproducts in serving as reliable biomarkers for oral cancer detection, prognosis and diagnosis.
Export Options
About this article
Cite this article as:
Hanafi R., Anestopoulos I., P. Voulgaridou G., Franco R., G. Georgakilas A., Ziech D., Malamou-Mitsi V., Pappa A. and I. Panayiotidis M., Oxidative Stress Based-Biomarkers in Oral Carcinogenesis: How Far Have We Gone?, Current Molecular Medicine 2012; 12 (6) . https://dx.doi.org/10.2174/156652412800792598
DOI https://dx.doi.org/10.2174/156652412800792598 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Application of Pharmacogenomics to Dietary Cancer Chemoprevention
Current Pharmacogenomics T-Cell Zeta Chain Expression, Phosphorylation and Degradation and their Role in T-Cell Signal Transduction and Immune Response Regulation in Health And Disease
Current Signal Transduction Therapy EDITORIAL (Hot Topic: “Signal Transduction and Response to Anti-Cancer Therapy”)
Current Signal Transduction Therapy Treatment with Radix Euphorbiae Ebracteolatae Significantly Decreases the Expression of E6 and L1, and Increases the Expression of p53 and Rb in HPV18-infected Human Foreskin Keratinocytes
Current Molecular Medicine EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Current Cancer Drug Targets Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Optical Diagnosis of Head and Neck Cancers (Review)
Reviews on Recent Clinical Trials The Role of Growth Factors in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neurotoxicity
Current Drug Safety The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer
Current Pharmaceutical Design Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
Current Medicinal Chemistry The Coronin Family and Human Disease
Current Protein & Peptide Science Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design New Approaches to Providing Individualized Diabetes Care in the 21st Century
Current Diabetes Reviews Gallium in Cancer Treatment
Current Topics in Medicinal Chemistry Development of 96-microwell Plate Assay with Fluorescence Reader and HPLC Method with Fluorescence Detection for High-throughput Analysis of Linifanib in its Bulk and Dosage Forms
Current Pharmaceutical Analysis Neonatal Germ Cell Tumors
Current Pediatric Reviews Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature
Current Drug Targets Role of Liprins in the Regulation of Tumor Cell Motility and Invasion
Current Cancer Drug Targets Medicinal Plants Towards Modeling Skin Cancer
Current Drug Targets